Literature DB >> 33538231

Missense, silent, non-sense and frame-shift mutations in exon 3 of the filaggrin gene in patients with bronchial asthma, atopic dermatitis, allergic rhinitis and mixed atopy.

Ragaa H Salama1, Zafar Rasheed1, Ahmed A Ahmed2, Ghada A Bin Saif3, Maha M Elkholy4, Alaa E Abd El-Moniem4, Tarek Salem1, Khaled Zedan5, Ahmad A Al Robaee6, Abdullateef A Alzolibani6.   

Abstract

This study investigated the atopic march on the basis of genetics. This research detected 227 variants in the filaggrin gene (FLG gene). Missense, silent, non-sense, frame-shift and non-coding mutations were detected in exon 3 of the FLG gene in patients with bronchial asthma, atopic dermatitis, allergic rhinitis and mixed atopy. Missense mutation was detected at c.8343 G > C (p. Asp2781Glu) in all adult asthmatic and allergic rhinitis patients. Whereas, mutation at c.8360 C > T/A (p. Arg2787 His/Leu) was detected in all childhood asthmatic and mixed atopic patients. A non-coding mutation was detected at c.12365 in atopic dermatitis and bronchial asthma patients. Furthermore, DNA sequencing of asthmatic and mixed atopic patients showed missense mutations at c.6073 C > T (p. Gly2025Glu) and a silent mutation at c. 8341 G > A (p. Asp2781Asp).

Entities:  

Keywords:  Mutations; allergic rhinitis; asthma; atopic dermatitis; atopic march; filaggrin

Mesh:

Substances:

Year:  2021        PMID: 33538231     DOI: 10.1080/15257770.2021.1880009

Source DB:  PubMed          Journal:  Nucleosides Nucleotides Nucleic Acids        ISSN: 1525-7770            Impact factor:   1.381


  3 in total

Review 1.  The Discovery and Function of Filaggrin.

Authors:  J Kenneth Hoober; Laura L Eggink
Journal:  Int J Mol Sci       Date:  2022-01-27       Impact factor: 5.923

2.  Association of FLG mutation with tumor mutation load and clinical outcomes in patients with gastric cancer.

Authors:  Fu Yicheng; Liu Xin; Yu Tian; Liu Huilin
Journal:  Front Genet       Date:  2022-08-15       Impact factor: 4.772

3.  Keratosis pilaris and filaggrin loss-of-function mutations in patients with atopic dermatitis - Results of a Finnish cross-sectional study.

Authors:  Alexander Salava; Ville Salo; Anita Remitz
Journal:  J Dermatol       Date:  2022-05-26       Impact factor: 3.468

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.